22.38
price up icon1.54%   0.3566
 
loading

Vera Therapeutics Inc Azioni (VERA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
40.12%
80.14
57.19 48.91 49.80 37.34
Operating Income/Loss
40.12%
-80.14
-57.19 -48.91 -49.80 -37.34
Nonoperating Income/Loss
34.36%
3.61
5.50 5.49 3.169 3.635
Income/Loss From Continuing Operations Before Tax
48.05%
-76.53
-51.69 -43.42 -46.63 -33.71
Income/Loss From Continuing Operations After Tax
48.05%
-76.53
-51.69 -43.42 -46.63 -33.71
Net Income/Loss
48.05%
-76.53
-51.69 -43.42 -46.63 -33.71
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.18%
63.79
63.67 1.7888 54.90 54.73
Diluted Average Shares
0.18%
63.79
63.67 1.7888 54.90 54.73
Basic Earnings Per Share
48.15%
-1.20
-0.81 -0.72 -0.85 -0.62
Diluted Earnings Per Share
48.15%
-1.20
-0.81 -0.72 -0.85 -0.62
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$25.08
price up icon 1.45%
$84.24
price down icon 0.76%
$25.43
price up icon 2.60%
$102.25
price down icon 0.74%
$136.57
price up icon 1.43%
biotechnology ONC
$302.15
price up icon 0.67%
Capitalizzazione:     |  Volume (24 ore):